FDA Draft Guidance on Real-World Evidence: Regulatory Context
The new article highlights the aspects related to how the regulatory context should be considered when assessing real-world evidence and real-world data.
The new article highlights the aspects related to how the regulatory context should be considered when assessing real-world evidence and real-world data.
The article provides a brief overview of the applicable regulatory requirements related to using real-world data in the context of submissions associated with medical devices intended to be marketed and used in the US.
The article provides a brief overview of the approach to be followed for the reports related to studies and reports associated with it.
The article highlights the aspects related to the definition of shortage and the steps the authority takes to mitigate the associated risks.
The new article provides additional details regarding specific aspects associated with remote regulatory assessments.
The article highlights the critical points associated with the existing regulatory framework for remote regulatory assessments.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report